Presented on December 1st, 2021 | Duration: 55m
Outlines Abbott's findings on the new HIV subtype L and the importance of global viral surveillance. Discusses virus diversity and mutations within HIV and SARS-CoV-2 its impact on diagnostic testing, prevalence within the global and US populations (including the various subtypes that exist in HIV and SARS-CoV-2), and the importance of monitoring viral evolution and its impact on detection.

Presented on March 22nd, 2021 | Duration: 49m 51s
Viral diversity presents an ongoing challenge for diagnostic tests, which must be designed to accurately detect all current and future circulating strains. This webinar aims to help better understand viral diversity and the impact it has on diagnostic tools, explore the current state of SARS-CoV-2 surveillance, and discuss how to stay ahead of the next pandemic with Abbott’s Pandemic Defense Coalition.

Presented on March 29th, 2021 | Duration: 55m 48s
Alinity m Resp-4-Plex assay provides simultaneous qualitative detection and differentiation of Flu A, Flu B, Respiratory Syncytial Virus (RSV) and SARS-CoV-2 on the fully automated Alinity m system. This webinar will discuss the design, development and clinical performance of the Alinity m Resp-4-Plex assay.

Presented on July 8th, 2020 | Duration: 1h 14m
Discusses design and development of the SARS CoV-2 diagnostic assay as well as a review of different strategies on the implementation of SARS-CoV-2 molecular testing under FDA Emergency Use Authorization only (EUA) in a US Integrated Hospital Delivery Network (IDN).